NLS Pharmaceutics Prices Up to $1 Million Private Placement

MT Newswires Live

Dec 05, 2024

NLS Pharmaceutics (NLSP) said Wednesday it priced a private placement offering of up to 322,580 common shares at $3.10 per share for gross proceeds of up to $1 million.

The company said the initial closing of the offering amounting to $500,000 is expected to take place on or before Jan. 10, 2025.

At the election of the buyer, the subsequent closing of $500,000 may happen within 15 days after the receipt of shareholder approval and the common shares trading for at least 10 straight trading days higher than $3.10, corresponding to a premium of about 15%, the company added.

NLS plans to use the net proceeds for general corporate purposes.

The shares of NLS Pharmaceutics were up nearly 2% in recent trading.

Price: 2.74, Change: +0.04, Percent Change: +1.67

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2489439241"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2489439241\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2489439241?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-05 02:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2489439241","market":"fut","top_or_hot":-1,"title":"NLS Pharmaceutics Prices Up to $1 Million Private Placement","media":"MT Newswires Live","content":"<html><body><p> NLS Pharmaceutics (NLSP) said Wednesday it priced a private placement offering of up to 322,580 common shares at $3.10 per share for gross proceeds of up to $1 million.</p><p>The company said the initial closing of the offering amounting to $500,000 is expected to take place on or before Jan. 10, 2025.</p><p>At the election of the buyer, the subsequent closing of $500,000 may happen within 15 days after the receipt of shareholder approval and the common shares trading for at least 10 straight trading days higher than $3.10, corresponding to a premium of about 15%, the company added.</p><p>NLS plans to use the net proceeds for general corporate purposes.</p><p>The shares of NLS Pharmaceutics were up nearly 2% in recent trading.</p><p>Price: 2.74, Change: +0.04, Percent Change: +1.67</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>NLS Pharmaceutics Prices Up to $1 Million Private Placement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNLS Pharmaceutics Prices Up to $1 Million Private Placement\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2024-12-05 02:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> NLS Pharmaceutics (NLSP) said Wednesday it priced a private placement offering of up to 322,580 common shares at $3.10 per share for gross proceeds of up to $1 million.</p><p>The company said the initial closing of the offering amounting to $500,000 is expected to take place on or before Jan. 10, 2025.</p><p>At the election of the buyer, the subsequent closing of $500,000 may happen within 15 days after the receipt of shareholder approval and the common shares trading for at least 10 straight trading days higher than $3.10, corresponding to a premium of about 15%, the company added.</p><p>NLS plans to use the net proceeds for general corporate purposes.</p><p>The shares of NLS Pharmaceutics were up nearly 2% in recent trading.</p><p>Price: 2.74, Change: +0.04, Percent Change: +1.67</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2489439241","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2489439241","pubTimestamp":1733337742,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"NLS Pharmaceutics  said Wednesday it priced a private placement offering of up to 322,580 common shares at $3.10 per share for gross proceeds of up to $1 million.The company said the initial closing of the offering amounting to $500,000 is expected to take place on or before Jan. 10, 2025.At the election of the buyer, the subsequent closing of $500,000 may happen within 15 days after the receipt of shareholder approval and the common shares trading for at least 10 straight trading days higher than $3.10, corresponding to a premium of about 15%, the company added.NLS plans to use the net proceeds for general corporate purposes.The shares of NLS Pharmaceutics were up nearly 2% in recent trading.Price: 2.74, Change: +0.04, Percent Change: +1.67","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","NLSP":"NLS Pharmaceutics Ltd."},"translate_title":"NLS Pharmaceutics私募定价高达100万美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NLSP":1},"content_text":"NLS Pharmaceutics (NLSP) said Wednesday it priced a private placement offering of up to 322,580 common shares at $3.10 per share for gross proceeds of up to $1 million.The company said the initial closing of the offering amounting to $500,000 is expected to take place on or before Jan. 10, 2025.At the election of the buyer, the subsequent closing of $500,000 may happen within 15 days after the receipt of shareholder approval and the common shares trading for at least 10 straight trading days higher than $3.10, corresponding to a premium of about 15%, the company added.NLS plans to use the net proceeds for general corporate purposes.The shares of NLS Pharmaceutics were up nearly 2% in recent trading.Price: 2.74, Change: +0.04, Percent Change: +1.67","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}